| Application no. and date | 02719751.6 (espacenet) (Federated) (European Patent Register), 20020202 | | Patent/reg. no. and date | DK/EP 1385577, 20060419 | | Publication date | 20040204 | | Priority no. and date | EP 01109853, 20010423 | | EP pub. no. and date |
EP 1385577 20040204 | | Effective date | | | Applicant/owner | F. Hoffman-la Roche AG, 124 Grenzacherstrasse
4070 Basle, CH | | Applicant ref. no. | P40685DK01 | | Inventor | BUSER, Susanne, Huelftenstrasse 5
CH-4402 Frenkendorf, CH,
FORD, Anthony, P., D., W., 709 Tiana Lane
Mountain View, CA 94041, US,
LENZ, Barbara, Riedstrasse 3
79189 Bad Krozingen, DE,
SLEIGHT, Andrew John, Résidence Le Manoir,
3A, rue de la Lisiere
68400 Riedisheim, FR,
VANKAN, Pierre, Mythenstrasse 8
CH-4054 Basel, CH,
HOFFMANN, Torsten, Kleinhueninger Strasse 15
79576 Weil am Rhein, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/455 (2006.01) , A61P 13/08 (2006.01) | | Title | Anvendelse af NK-1-receptorantagonister mod godartet prostatahyperplasi | | Int. application no. | EP2002001085 | | Int. publication no. | WO2002085458 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
